David Krempa
Net worth: 768 832 $ as of 30/05/2026
Net worth: 768 832 $ as of 30/05/2026
David C.
Krempa formerly worked at Akorn, Inc., as Head-Business Development, Sagent Pharmaceuticals, Inc., as Head-Business Development, and Morningstar, Inc. (Research), as Equity Analyst from 2014 to 2015.
Mr. Krempa received his undergraduate degree from DePaul University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/05/2026 | 25,249 ( 0.09% ) | 768 832 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ETON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 28/02/2023 |
| Companies | Position | End |
|---|---|---|
Morningstar, Inc. (Research)
Morningstar, Inc. (Research) Investment ManagersFinance Provides investment research | Analyst-Equity | 28/02/2015 |
| SAGENT PHARMACEUTICALS INC | Corporate Officer/Principal | - |
| AKORN, INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Akorn, Inc.
Akorn, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes therapeutic, diagnostic & surgical pharmaceuticals | Health Technology |
DePaul University
DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Morningstar, Inc. (Research)
Morningstar, Inc. (Research) Investment ManagersFinance Provides investment research | Finance |
Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes prescription drug products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions